Infectious Disease HIV Treatment Guidelines
34 flashcards covering Infectious Disease HIV Treatment Guidelines for the HEALTHCARE-CE Physician CME section.
The Infectious Disease HIV Treatment Guidelines provide comprehensive recommendations for the management and treatment of HIV, as defined by the U.S. Department of Health and Human Services (DHHS). These guidelines encompass various aspects of care, including antiretroviral therapy initiation, monitoring, and management of co-morbid conditions. Staying updated with these guidelines is essential for healthcare professionals to ensure effective patient outcomes and adherence to best practices.
In practice exams and competency assessments, questions about HIV treatment guidelines often focus on specific medication regimens, patient eligibility criteria, and management strategies for treatment-resistant cases. Common traps include confusing first-line therapies with alternatives or overlooking the importance of patient adherence and follow-up care. A frequent oversight is neglecting to assess patients for potential drug interactions, which can significantly impact treatment efficacy.
Terms (34)
- 01
What is the recommended initial therapy for most adults with HIV infection?
The recommended initial therapy for most adults with HIV infection is a combination of two nucleoside reverse transcriptase inhibitors (NRTIs) and a third agent, which may be an integrase strand transfer inhibitor (INSTI), a non-nucleoside reverse transcriptase inhibitor (NNRTI), or a protease inhibitor (IDSA Clinical Practice Guidelines).
- 02
How often should patients on antiretroviral therapy be monitored for viral load?
Patients on antiretroviral therapy should have their viral load monitored at least every 3 to 6 months to ensure treatment efficacy (IDSA Clinical Practice Guidelines).
- 03
What is the goal of antiretroviral therapy in HIV treatment?
The goal of antiretroviral therapy in HIV treatment is to achieve and maintain viral suppression, defined as an undetectable viral load (IDSA Clinical Practice Guidelines).
- 04
Under the IDSA guidelines, when should HIV treatment be initiated?
HIV treatment should be initiated as soon as possible after diagnosis, regardless of CD4 count, to improve health outcomes and reduce transmission (IDSA Clinical Practice Guidelines).
- 05
What is the recommended follow-up for patients with HIV after starting treatment?
Follow-up for patients with HIV after starting treatment should include monitoring for adherence, side effects, and viral load, typically within 2 to 8 weeks after initiation, and then every 3 to 6 months thereafter (IDSA Clinical Practice Guidelines).
- 06
When should resistance testing be performed in HIV patients?
Resistance testing should be performed at baseline before initiating therapy and for patients experiencing virologic failure (IDSA Clinical Practice Guidelines).
- 07
What is the role of PrEP in HIV prevention?
Pre-exposure prophylaxis (PrEP) is recommended for individuals at high risk of HIV infection to reduce the risk of acquiring HIV when taken consistently (USPSTF Recommendations).
- 08
What is the recommended treatment for HIV-associated opportunistic infections?
The recommended treatment for HIV-associated opportunistic infections varies by specific infection; for example, Pneumocystis pneumonia is treated with trimethoprim-sulfamethoxazole (IDSA Clinical Practice Guidelines).
- 09
How often should HIV-positive pregnant women be monitored during pregnancy?
HIV-positive pregnant women should be monitored at least every trimester for viral load and CD4 count to ensure effective management and reduce the risk of transmission to the infant (IDSA Clinical Practice Guidelines).
- 10
What is the recommended action for a patient with a detectable viral load on ART?
For a patient with a detectable viral load on antiretroviral therapy, the recommended action is to assess adherence, evaluate for drug resistance, and consider a change in therapy if necessary (IDSA Clinical Practice Guidelines).
- 11
What is the significance of a CD4 count in HIV management?
A CD4 count is significant in HIV management as it helps determine the stage of HIV infection, guides treatment decisions, and assesses the risk of opportunistic infections (IDSA Clinical Practice Guidelines).
- 12
What is the recommended frequency of CD4 count monitoring for stable HIV patients?
For stable HIV patients on effective antiretroviral therapy, CD4 counts should be monitored every 6 to 12 months (IDSA Clinical Practice Guidelines).
- 13
What is the first-line treatment for HIV-related wasting syndrome?
The first-line treatment for HIV-related wasting syndrome includes nutritional support and, in some cases, the use of appetite stimulants or anabolic agents (IDSA Clinical Practice Guidelines).
- 14
What is the recommended prophylaxis for opportunistic infections in HIV patients?
Prophylaxis for opportunistic infections in HIV patients is recommended when the CD4 count is below 200 cells/mm³, with specific regimens depending on the infection risk (IDSA Clinical Practice Guidelines).
- 15
When should HIV patients be screened for tuberculosis?
HIV patients should be screened for tuberculosis at the time of HIV diagnosis and periodically thereafter, especially if they have risk factors (IDSA Clinical Practice Guidelines).
- 16
What is the importance of adherence to antiretroviral therapy?
Adherence to antiretroviral therapy is crucial for achieving and maintaining viral suppression, preventing drug resistance, and improving overall health outcomes (IDSA Clinical Practice Guidelines).
- 17
What is the recommended management for HIV patients with acute renal failure?
Management for HIV patients with acute renal failure includes assessing the cause, adjusting antiretroviral therapy as needed, and providing supportive care (IDSA Clinical Practice Guidelines).
- 18
What are the key components of a comprehensive HIV care plan?
A comprehensive HIV care plan should include antiretroviral therapy, regular monitoring of viral load and CD4 count, management of comorbidities, and psychosocial support (IDSA Clinical Practice Guidelines).
- 19
How should HIV treatment be adjusted for patients with hepatic impairment?
HIV treatment should be adjusted for patients with hepatic impairment based on the degree of liver dysfunction, with careful selection of antiretroviral agents (IDSA Clinical Practice Guidelines).
- 20
What is the role of integrase inhibitors in HIV treatment?
Integrase inhibitors are a preferred class of antiretroviral agents due to their high efficacy, low resistance potential, and favorable side effect profile (IDSA Clinical Practice Guidelines).
- 21
What is the recommended approach for managing HIV in adolescents?
The recommended approach for managing HIV in adolescents includes age-appropriate counseling, adherence support, and consideration of developmental issues in treatment planning (IDSA Clinical Practice Guidelines).
- 22
What is the significance of viral load testing in HIV management?
Viral load testing is significant in HIV management as it provides information on the effectiveness of therapy and helps guide treatment decisions (IDSA Clinical Practice Guidelines).
- 23
What is the recommended action for a patient experiencing side effects from HIV medication?
For a patient experiencing side effects from HIV medication, the recommended action is to evaluate the severity of the side effects and consider switching to an alternative regimen if necessary (IDSA Clinical Practice Guidelines).
- 24
What is the recommended follow-up for HIV-positive patients after starting ART?
The recommended follow-up for HIV-positive patients after starting ART includes monitoring for viral load and CD4 count at 2 to 8 weeks, then every 3 to 6 months (IDSA Clinical Practice Guidelines).
- 25
What is the role of combination therapy in HIV treatment?
Combination therapy in HIV treatment is essential to reduce the risk of drug resistance and to achieve optimal viral suppression (IDSA Clinical Practice Guidelines).
- 26
How should HIV patients be educated about transmission risks?
HIV patients should be educated about transmission risks, including safe sex practices and the importance of adherence to therapy to maintain an undetectable viral load (IDSA Clinical Practice Guidelines).
- 27
What is the recommended treatment for HIV-associated neurocognitive disorders?
The recommended treatment for HIV-associated neurocognitive disorders includes optimizing antiretroviral therapy and addressing any coexisting conditions (IDSA Clinical Practice Guidelines).
- 28
What is the importance of routine laboratory monitoring in HIV care?
Routine laboratory monitoring in HIV care is important for assessing treatment efficacy, detecting complications, and guiding therapeutic decisions (IDSA Clinical Practice Guidelines).
- 29
What is the recommended strategy for preventing HIV transmission during pregnancy?
The recommended strategy for preventing HIV transmission during pregnancy includes initiating antiretroviral therapy as early as possible and maintaining viral suppression throughout pregnancy (IDSA Clinical Practice Guidelines).
- 30
What is the significance of early diagnosis and treatment of HIV?
Early diagnosis and treatment of HIV are significant as they improve long-term health outcomes, reduce morbidity and mortality, and decrease the risk of transmission (IDSA Clinical Practice Guidelines).
- 31
What is the recommended approach for managing HIV in older adults?
The recommended approach for managing HIV in older adults includes considering comorbidities, potential drug interactions, and tailoring therapy to individual needs (IDSA Clinical Practice Guidelines).
- 32
What is the role of patient education in HIV management?
Patient education plays a crucial role in HIV management by promoting adherence, reducing stigma, and empowering patients to take an active role in their care (IDSA Clinical Practice Guidelines).
- 33
What is the recommended follow-up for patients with HIV and hepatitis co-infection?
The recommended follow-up for patients with HIV and hepatitis co-infection includes regular monitoring of liver function and adjusting HIV therapy as needed (IDSA Clinical Practice Guidelines).
- 34
What is the significance of maintaining an undetectable viral load in HIV patients?
Maintaining an undetectable viral load in HIV patients is significant as it prevents transmission of the virus to sexual partners and improves overall health (IDSA Clinical Practice Guidelines).